ArticleFrontiers in public health2026
Development and validation of a novel model based on hematological biomarkers for predicting risk factors and outcomes in cancer patients with carbapenem-resistant organism infection.
Bin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.